Tag: gene expression market forecast

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Gene Expression Market Size And Revenue Outlook Through 2030

The gene expression market has seen rapid expansion in recent years. It is projected to increase from $12.67 billion in 2025 to $14.16 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.7%. This historical growth can be attributed to several factors, including the increase in academic genomics research funding, the growing prevalence of chronic and genetic diseases, the early adoption of microarray technologies, the expansion of pharmaceutical R&D pipelines, and the rising utilization of PCR-based techniques.

The gene expression market is projected to experience substantial growth over the coming years. Its valuation is anticipated to reach $22.22 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 11.9%. This growth during the projected period can be ascribed to advancements in RNA sequencing technologies, a heightened emphasis on precision medicine, expansion in clinical diagnostics applications, the incorporation of AI into gene expression data analysis, and increased investments within the biotechnology industry. Key trends expected over the forecast horizon encompass the broadening of single-cell gene expression analysis, enhanced utilization of spatial transcriptomics, an increasing need for high-throughput PCR platforms, the growing acceptance of multi-omics integration, and the establishment of standardized gene expression workflows.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=60111260&type=smp&name=Gene%20Expression%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Gene Expression Market Growth Backed By Core Demand Fundamentals

The future expansion of the gene expression market is anticipated to be propelled by the increasing prevalence of chronic diseases. These are defined as long-term medical conditions that persist for an extended duration, typically three months or more. Gene expression analysis is instrumental in chronic diseases for deciphering the underlying molecular mechanisms, pinpointing potential biomarkers, and developing targeted therapeutic approaches. For example, as reported in June 2024 by the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) received a diagnosis of non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023. This figure marked an 18% increase from the 3,065,825 cases observed in 2022. Thus, the growing incidence of chronic diseases will be a significant driver for the gene expression market’s growth.

Gene Expression Market Segment Analysis Spotlighting Growth Areas

The gene expression market covered in this report is segmented –

1) By Product: Kits And Reagents, DNA Chip Or Microarray, Other Products

2) By Process: Sample Collection, Purification, cDNA Synthesis And Conversion, PCR Analysis, Data Analysis And Interpretation

3) By Technique: RNA Exp, Promoter Analysis, Protein Exp. And Posttranslational Modification Analysis

4) By Application: Drug Discovery And Development, Clinical Diagnostics, Biotechnology And Microbiology, Other Applications

Subsegments:

1) By Kits And Reagents: RNA Isolation Kits, cDNA Synthesis Kits, qPCR Kits, Reverse Transcription Kits, Other Reagents

2) By DNA Chip Or Microarray: Expression Microarrays, Genotyping Microarrays, Comparative Genomic Hybridization Arrays

3) By Other Products: Software For Data Analysis, Lab Instruments, Consumables

Gene Expression Market Growth Trends Reshaping The Competitive Landscape

Leading companies in the gene expression market are concentrating on developing innovative products, such as gene detection assays, to achieve a competitive advantage and increase their revenue. A gene detection assay within gene expression refers to a method for identifying and quantifying genetic molecules, offering insights into the activity and abundance of specific genes. For instance, in January 2023, Bio-Techne Corporation, a US-based biotech company specializing in research instruments, expanded its Advanced Cell Diagnostics (ACD)-branded RNAscope in situ hybridization (ISH) portfolio by introducing the RNAscope Plus smRNA-RNA detection assay. This new assay enables the simultaneous fluorescent detection of a small regulatory RNA alongside three target RNAs or RNA biomarkers in a single tissue section, providing single-cell and subcellular resolution. Designed to accommodate large studies, the assay is compatible with the Leica Bond Rx platform and is available as a manual assay for convenient use. These therapeutic nucleic acids hold the potential to modulate the expression and functionality of specific target genes, thereby facilitating the creation of customized treatments for inherited or acquired diseases that have proven resistant to conventional therapies.

Gene Expression Market Leading Companies: Who Holds The Strongest Market Presence?

Major companies operating in the gene expression market are Thermo Fisher Scientific Inc., Qiagen NV, Illumina Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc., PerkinElmer Inc., GE Healthcare, F Hoffmann-La Roche Ltd, Oxford Gene Technology IP Limited, Promega Corporation, OriGene Technologies Inc., Luminex Corporation, Takara Bio Inc., Danaher Corporation, ELITechGroup, Biocartis Group NV, Integragen SA, Oxford Nanopore Technologies Limited, Phalanx Biotech Group, Roche Holding AG, Sengenics Corporation Pte Ltd., GenXPro GmbH, Twist Bioscience Corporation, Zymo Research Corporation, Abcam plc., Bio-Techne Corporation

View The Full Gene Expression Market Report:

https://thebusinessresearchcompany.com/report/gene-expression-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Gene Expression Market Largest Region: Which Geography Holds The Biggest Share?

North America was the largest region in the gene expression market in 2025. Asia-Pacific is expected to be the fastest-growing region in the gene expression market in the forecast period. The regions covered in the gene expression market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Gene Expression Market Size Outlook: How Fast Will Revenue Grow Through 2030?

The market for gene expression experienced significant expansion over the last few years, increasing from $12.67 billion in 2025 to $14.16 billion in 2026, representing a compound annual growth rate (CAGR) of 11.7%. This historical growth was driven by several factors, including higher funding for academic genomics research, a growing frequency of chronic and genetic disorders, the early implementation of microarray technologies, the widening of pharmaceutical research and development pipelines, and the increased utilization of PCR-based methods.

The gene expression market is anticipated to experience substantial growth over the coming years. By 2030, it is projected to reach a valuation of $22.22 billion, driven by a compound annual growth rate (CAGR) of 11.9%. This upward trajectory in the forecast period is fueled by progress in RNA sequencing technologies, a heightened emphasis on precision medicine, the expansion of clinical diagnostic applications, the incorporation of artificial intelligence into gene expression data analysis, and growing investments within the biotechnology sector. Key developments shaping the forecast period involve the broadening scope of single-cell gene expression analysis, the rising application of spatial transcriptomics, the escalating need for high-throughput PCR platforms, an increased uptake of multi-omics integration, and the establishment of standardized gene expression workflows.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9156&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Gene Expression Market Demand Drivers: What Is Fueling Industry Growth?

The increasing prevalence of chronic illnesses is anticipated to boost the gene expression market in the coming years. Chronic diseases are extended medical conditions that last for a lengthy duration, typically three months or more. Gene expression analysis is applied to such diseases to decipher the molecular processes behind them, detect possible biomarkers, and create targeted treatments. For example, in June 2024, the National Health Service, a UK government agency, reported that 3,615,330 patients registered with a general practitioner were identified with non-diabetic hyperglycemia or pre-diabetes—a condition characterized by high blood sugar levels that do not yet meet diabetes criteria—in 2023. This figure reflects an 18% rise compared to 3,065,825 cases documented in 2022. Consequently, the growing incidence of chronic diseases is set to fuel the expansion of the gene expression market.

Gene Expression Market Segmentation Trends And Revenue Drivers

The gene expression market covered in this report is segmented –

1) By Product: Kits And Reagents, DNA Chip Or Microarray, Other Products

2) By Process: Sample Collection, Purification, cDNA Synthesis And Conversion, PCR Analysis, Data Analysis And Interpretation

3) By Technique: RNA Exp, Promoter Analysis, Protein Exp. And Posttranslational Modification Analysis

4) By Application: Drug Discovery And Development, Clinical Diagnostics, Biotechnology And Microbiology, Other Applications

Subsegments:

1) By Kits And Reagents: RNA Isolation Kits, cDNA Synthesis Kits, qPCR Kits, Reverse Transcription Kits, Other Reagents

2) By DNA Chip Or Microarray: Expression Microarrays, Genotyping Microarrays, Comparative Genomic Hybridization Arrays

3) By Other Products: Software For Data Analysis, Lab Instruments, Consumables

Gene Expression Market Innovation Trends: Which Developments Are Transforming The Industry?

Major industry players in the gene expression space are concentrating on creating cutting-edge products like gene detection assays to secure a market edge and boost their earnings. A gene detection assay within gene expression refers to a technique used to identify and measure the presence of genetic molecules, offering clarity on the activity and abundance of particular genes. In January 2023, for example, Bio-Techne Corporation, a biotech firm headquartered in the US that specializes in research instruments, broadened its Advanced Cell Diagnostics (ACD) branded RNAscope in situ hybridization (ISH) lineup by unveiling the RNAscope Plus smRNA-RNA detection assay. This novel assay enables the simultaneous fluorescent detection of a small regulatory RNA along with three target RNAs or RNA biomarkers within a single tissue section, achieving resolution at the single-cell and subcellular level. Created to support large-scale studies, the assay works seamlessly with the Leica Bond Rx platform and is also offered as a manual assay for ease of use. Such therapeutic nucleic acids hold the capacity to alter the expression and function of specific target genes, paving the way for the development of personalized treatments for inherited or acquired diseases that have resisted conventional approaches.

Gene Expression Market Industry Leaders: Which Organizations Are Driving Competition?

Major companies operating in the gene expression market are Thermo Fisher Scientific Inc., Qiagen NV, Illumina Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc., PerkinElmer Inc., GE Healthcare, F Hoffmann-La Roche Ltd, Oxford Gene Technology IP Limited, Promega Corporation, OriGene Technologies Inc., Luminex Corporation, Takara Bio Inc., Danaher Corporation, ELITechGroup, Biocartis Group NV, Integragen SA, Oxford Nanopore Technologies Limited, Phalanx Biotech Group, Roche Holding AG, Sengenics Corporation Pte Ltd., GenXPro GmbH, Twist Bioscience Corporation, Zymo Research Corporation, Abcam plc., Bio-Techne Corporation

Access The Complete Gene Expression Market Report:

https://www.thebusinessresearchcompany.com/report/gene-expression-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Gene Expression Market Largest Region By Revenue And Market Share

North America was the largest region in the gene expression market in 2025. Asia-Pacific is expected to be the fastest-growing region in the gene expression market in the forecast period. The regions covered in the gene expression market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Expected Market Value Outlook For The Gene Expression Market Through 2030?

The gene expression market has seen considerable growth over recent years. It is projected to expand from $12.67 billion in 2025 to $14.16 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.7%. This historical growth can be ascribed to elements like increased academic genomics research funding, a rise in the prevalence of chronic and genetic diseases, the initial adoption of microarray technologies, the expansion of pharmaceutical R&D pipelines, and the growing application of PCR-based techniques.

The gene expression market is projected to expand significantly over the coming years, reaching $22.22 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.9%. This anticipated growth is driven by several factors, including advancements in RNA sequencing technologies, a heightened emphasis on precision medicine, the expansion of clinical diagnostics applications, the incorporation of AI into gene expression data analysis, and increased investments within the biotechnology industry. Key trends expected during this period involve the broader adoption of single-cell gene expression analysis, a rise in the application of spatial transcriptomics, increased demand for high-throughput PCR platforms, the growing integration of multi-omics approaches, and the standardization of gene expression workflows.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9156&type=smp

What Influential Factors Are Boosting The Gene Expression Market Demand?

The anticipated expansion of the gene expression market is significantly influenced by the increasing prevalence of chronic diseases. These conditions are defined as enduring medical ailments that last for an extended duration, usually exceeding three months. Gene expression analysis finds application in chronic disease management by aiding in the comprehension of their underlying molecular processes, the discovery of potential biomarkers, and the formulation of precise treatment strategies. As an illustration, data from June 2024, sourced from the National Health Service, a UK-based government department, revealed that 3,615,330 individuals registered with a general practitioner (GP) received a diagnosis of non-diabetic hyperglycemia or pre-diabetes (a condition characterized by elevated blood sugar levels, though not severe enough for a diabetes classification) in 2023. This represented an 18% increase from the 3,065,825 cases recorded in 2022. Consequently, the expanding incidence of chronic diseases is poised to fuel the expansion of the gene expression market.

How Is Segment Classification Applied In The Gene Expression Market?

The gene expression market covered in this report is segmented –

1) By Product: Kits And Reagents, DNA Chip Or Microarray, Other Products

2) By Process: Sample Collection, Purification, cDNA Synthesis And Conversion, PCR Analysis, Data Analysis And Interpretation

3) By Technique: RNA Exp, Promoter Analysis, Protein Exp. And Posttranslational Modification Analysis

4) By Application: Drug Discovery And Development, Clinical Diagnostics, Biotechnology And Microbiology, Other Applications

Subsegments:

1) By Kits And Reagents: RNA Isolation Kits, cDNA Synthesis Kits, qPCR Kits, Reverse Transcription Kits, Other Reagents

2) By DNA Chip Or Microarray: Expression Microarrays, Genotyping Microarrays, Comparative Genomic Hybridization Arrays

3) By Other Products: Software For Data Analysis, Lab Instruments, Consumables

What Trends Are Influencing The Gene Expression Market?

Leading companies in the gene expression market are prioritizing the creation of innovative products, such as gene detection assays, to achieve a competitive edge and increase their revenue. Within gene expression, a gene detection assay is a technique for identifying and measuring the presence of genetic molecules, offering insights into the activity and quantity of particular genes. For example, in January 2023, Bio-Techne Corporation, a US-based biotech company specializing in research instruments, expanded its Advanced Cell Diagnostics (ACD)-branded RNAscope in situ hybridization (ISH) portfolio by launching the RNAscope Plus smRNA-RNA detection assay. This novel assay permits the concurrent fluorescent identification of a small regulatory RNA alongside three target RNAs or RNA biomarkers in a single tissue section, providing single-cell and subcellular resolution. Tailored for extensive studies, the assay is compatible with the Leica Bond Rx platform and is offered as a manual assay for straightforward use. These therapeutic nucleic acids possess the capability to modulate the expression and functionality of specific target genes, thus enabling the development of personalized treatments for inherited or acquired diseases that have proven resistant to conventional therapies.

Who Are The Firms Contributing To The Gene Expression Market Ecosystem?

Major companies operating in the gene expression market are Thermo Fisher Scientific Inc., Qiagen NV, Illumina Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc., PerkinElmer Inc., GE Healthcare, F Hoffmann-La Roche Ltd, Oxford Gene Technology IP Limited, Promega Corporation, OriGene Technologies Inc., Luminex Corporation, Takara Bio Inc., Danaher Corporation, ELITechGroup, Biocartis Group NV, Integragen SA, Oxford Nanopore Technologies Limited, Phalanx Biotech Group, Roche Holding AG, Sengenics Corporation Pte Ltd., GenXPro GmbH, Twist Bioscience Corporation, Zymo Research Corporation, Abcam plc., Bio-Techne Corporation

Access The Complete Gene Expression Market Report:

https://www.thebusinessresearchcompany.com/report/gene-expression-global-market-report

Which Region Accounts For The Highest Share Of The Gene Expression Market?

North America was the largest region in the gene expression market in 2025. Asia-Pacific is expected to be the fastest-growing region in the gene expression market in the forecast period. The regions covered in the gene expression market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Gene Expression Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=9156&type=smp

Browse Through More Reports Similar to the Global Gene Expression Market 2026, By The Business Research Company

Gene Expression Market Report 2026

https://www.thebusinessresearchcompany.com/report/gene-expression-global-market-report

Protein Expression Market Report 2026

https://www.thebusinessresearchcompany.com/report/protein-expression-global-market-report

Gene Synthesis Market Report 2026

https://www.thebusinessresearchcompany.com/report/gene-synthesis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Market Size Of The Gene Expression Market In 2026, And How Will Its Value Evolve By 2030?

The gene expression market size has experienced rapid expansion in recent years. It is anticipated to increase from $12.67 billion in 2025 to $14.16 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.7%. The growth observed in the historical period is attributable to several factors, including increased funding for academic genomics research, the rising prevalence of chronic and genetic diseases, the early adoption of microarray technologies, the expansion of pharmaceutical R&D pipelines, and the growing utilization of PCR-based techniques.

The gene expression market is projected for significant expansion in the coming years, with its size anticipated to reach $22.22 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.9%. This growth throughout the forecast period stems from various factors, including advancements in RNA sequencing technologies, an increasing focus on precision medicine, the proliferation of clinical diagnostics applications, the integration of AI into gene expression data analysis, and expanding investments within the biotechnology industry. Major developments expected during this period include the wider application of single-cell gene expression analysis, a rise in the use of spatial transcriptomics, growing demand for high-throughput PCR platforms, the increasing adoption of multi-omics integration, and the standardization of gene expression workflows.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9156&type=smp

Which Primary Drivers Are Impacting The Gene Expression Market Growth?

The increasing prevalence of chronic diseases is projected to stimulate the expansion of the gene expression market moving forward. Chronic diseases are long-term health conditions that endure for an extended duration, typically three months or more. Gene expression analysis is employed in these conditions to unravel their underlying molecular mechanisms, pinpoint potential biomarkers, and formulate targeted therapeutic strategies. For instance, in June 2024, data from the National Health Service, a UK-based government department, revealed that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition marked by elevated blood sugar levels, not severe enough to be classified as diabetes) in 2023. This marked an 18% increase from 3,065,825 cases in 2022. Thus, the escalation in chronic diseases will propel the growth of the gene expression market.

What Segment Categories Shape The Gene Expression Market Segment Landscape?

The gene expression market covered in this report is segmented –

1) By Product: Kits And Reagents, DNA Chip Or Microarray, Other Products

2) By Process: Sample Collection, Purification, cDNA Synthesis And Conversion, PCR Analysis, Data Analysis And Interpretation

3) By Technique: RNA Exp, Promoter Analysis, Protein Exp. And Posttranslational Modification Analysis

4) By Application: Drug Discovery And Development, Clinical Diagnostics, Biotechnology And Microbiology, Other Applications

Subsegments:

1) By Kits And Reagents: RNA Isolation Kits, cDNA Synthesis Kits, qPCR Kits, Reverse Transcription Kits, Other Reagents

2) By DNA Chip Or Microarray: Expression Microarrays, Genotyping Microarrays, Comparative Genomic Hybridization Arrays

3) By Other Products: Software For Data Analysis, Lab Instruments, Consumables

Which Trends Are Guiding The Direction Of The Gene Expression Market?

Leading companies in the gene expression market are concentrating on developing innovative products, such as gene detection assays, to gain a competitive edge and boost revenue. A gene detection assay within gene expression refers to a method for pinpointing and quantifying genetic molecules, offering insights into the activity and abundance of specific genes. For instance, in January 2023, Bio-Techne Corporation, a US-based biotech company specializing in research instruments, expanded its Advanced Cell Diagnostics (ACD)-branded RNAscope in situ hybridization (ISH) portfolio by launching the RNAscope Plus smRNA-RNA detection assay. This new assay facilitates the simultaneous fluorescent identification of a small regulatory RNA along with three target RNAs or RNA biomarkers in a single tissue section, providing single-cell and subcellular resolution. Tailored for large studies, the assay is compatible with the Leica Bond Rx platform and is available as a manual assay for convenient application. These therapeutic nucleic acids hold the potential to modify the expression and functionality of specific target genes, thereby enabling the creation of customized treatments for inherited or acquired diseases that have proven resistant to conventional therapies.

Who Are The Companies Operating Across The Gene Expression Market Value Chain?

Major companies operating in the gene expression market are Thermo Fisher Scientific Inc., Qiagen NV, Illumina Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc., PerkinElmer Inc., GE Healthcare, F Hoffmann-La Roche Ltd, Oxford Gene Technology IP Limited, Promega Corporation, OriGene Technologies Inc., Luminex Corporation, Takara Bio Inc., Danaher Corporation, ELITechGroup, Biocartis Group NV, Integragen SA, Oxford Nanopore Technologies Limited, Phalanx Biotech Group, Roche Holding AG, Sengenics Corporation Pte Ltd., GenXPro GmbH, Twist Bioscience Corporation, Zymo Research Corporation, Abcam plc., Bio-Techne Corporation

Get The Full Gene Expression Market Report:

https://www.thebusinessresearchcompany.com/report/gene-expression-global-market-report

Which Region Leads The Gene Expression Market In Overall Market Size?

North America was the largest region in the gene expression market in 2025. Asia-Pacific is expected to be the fastest-growing region in the gene expression market in the forecast period. The regions covered in the gene expression market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Gene Expression Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/gene-expression-global-market-report

Browse Through More Reports Similar to the Global Gene Expression Market 2026, By The Business Research Company

Gene Expression Market Report 2026

https://www.thebusinessresearchcompany.com/report/gene-expression-global-market-report

Protein Expression Market Report 2026

https://www.thebusinessresearchcompany.com/report/protein-expression-global-market-report

Gene Synthesis Market Report 2026

https://www.thebusinessresearchcompany.com/report/gene-synthesis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Gene Expression Market During The Forecast Period 2026–2030?

The gene expression market has experienced significant expansion in recent years. It is projected to expand from $12.67 billion in 2025 to $14.16 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.7%. The historical growth of this market can be ascribed to several factors including increased funding for academic genomics research, the rising incidence of chronic and genetic diseases, the initial adoption of microarray technologies, the broadening of pharmaceutical R&D pipelines, and the increasing utilization of PCR-based techniques.

The gene expression market is projected for significant expansion over the coming years, reaching a valuation of $22.22 billion by 2030, propelled by a compound annual growth rate (CAGR) of 11.9%. This projected expansion during the forecast period is primarily driven by advancements in RNA sequencing technologies, a heightened emphasis on precision medicine, the proliferation of clinical diagnostics applications, the incorporation of AI into gene expression data analysis, and rising investments within the biotechnology industry. Key trends anticipated during this period encompass the broadening of single-cell gene expression analysis, a surge in the application of spatial transcriptomics, an increasing need for high-throughput PCR platforms, wider acceptance of multi-omics integration, and the establishment of standardized gene expression workflows.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9156&type=smp

Which Major Factors Are Driving The Expansion Of The Gene Expression Market?

The increasing prevalence of chronic diseases is anticipated to fuel the expansion of the gene expression market in the future. These are defined as medical conditions that endure for an extended duration, usually exceeding three months. Gene expression analysis plays a crucial role in chronic disease research, helping to elucidate their molecular foundations, pinpoint potential biomarkers, and formulate specific therapeutic approaches. As an illustration, figures from June 2024, reported by the National Health Service, a UK-based government department, revealed that 3,615,330 patients registered with a general practitioner (GP) received a diagnosis of non-diabetic hyperglycemia or pre-diabetes (a state characterized by elevated blood sugar levels insufficient for a diabetes diagnosis) in 2023. This represented an 18% surge from 3,065,825 instances recorded in 2022. Consequently, the growing incidence of chronic diseases is set to be a significant catalyst for the gene expression market’s growth.

What Market Segments Are Evaluated Within The Gene Expression Market?

The gene expression market covered in this report is segmented –

1) By Product: Kits And Reagents, DNA Chip Or Microarray, Other Products

2) By Process: Sample Collection, Purification, cDNA Synthesis And Conversion, PCR Analysis, Data Analysis And Interpretation

3) By Technique: RNA Exp, Promoter Analysis, Protein Exp. And Posttranslational Modification Analysis

4) By Application: Drug Discovery And Development, Clinical Diagnostics, Biotechnology And Microbiology, Other Applications

Subsegments:

1) By Kits And Reagents: RNA Isolation Kits, cDNA Synthesis Kits, qPCR Kits, Reverse Transcription Kits, Other Reagents

2) By DNA Chip Or Microarray: Expression Microarrays, Genotyping Microarrays, Comparative Genomic Hybridization Arrays

3) By Other Products: Software For Data Analysis, Lab Instruments, Consumables

What Industry Trends Are Redefining The Gene Expression Market?

Leading companies in the gene expression market are concentrating on creating novel offerings, like gene detection assays, to secure a competitive edge and boost their income. Within gene expression, a gene detection assay is a technique used to pinpoint and measure genetic molecules, revealing information about the activity and quantity of particular genes. As an illustration, in January 2023, Bio-Techne Corporation, a US-based biotech firm known for research instruments, broadened its Advanced Cell Diagnostics (ACD)-branded RNAscope in situ hybridization (ISH) range with the launch of the RNAscope Plus smRNA-RNA detection assay. This novel assay enables the simultaneous fluorescent identification of a small regulatory RNA together with three target RNAs or RNA biomarkers within one tissue section, providing resolution at both single-cell and subcellular levels. Suitable for extensive studies, this assay is compatible with the Leica Bond Rx platform and is offered as a manual assay for ease of operation. These therapeutic nucleic acids hold the capacity to adjust the expression and function of particular target genes, thus enabling the development of personalized treatments for inherited or acquired diseases that have shown resistance to standard therapies.

Who Are The Top Market Participants Influencing The Gene Expression Market?

Major companies operating in the gene expression market are Thermo Fisher Scientific Inc., Qiagen NV, Illumina Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc., PerkinElmer Inc., GE Healthcare, F Hoffmann-La Roche Ltd, Oxford Gene Technology IP Limited, Promega Corporation, OriGene Technologies Inc., Luminex Corporation, Takara Bio Inc., Danaher Corporation, ELITechGroup, Biocartis Group NV, Integragen SA, Oxford Nanopore Technologies Limited, Phalanx Biotech Group, Roche Holding AG, Sengenics Corporation Pte Ltd., GenXPro GmbH, Twist Bioscience Corporation, Zymo Research Corporation, Abcam plc., Bio-Techne Corporation

Read the full gene expression market report here:

https://www.thebusinessresearchcompany.com/report/gene-expression-global-market-report

Which Region Currently Holds The Largest Share Of The Gene Expression Market?

North America was the largest region in the gene expression market in 2025. Asia-Pacific is expected to be the fastest-growing region in the gene expression market in the forecast period. The regions covered in the gene expression market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Gene Expression Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9156&type=smp

Browse Through More Reports Similar to the Global Gene Expression Market 2026, By The Business Research Company

Gene Expression Market Report 2026

https://www.thebusinessresearchcompany.com/report/gene-expression-global-market-report

Protein Expression Market Report 2026

https://www.thebusinessresearchcompany.com/report/protein-expression-global-market-report

Gene Synthesis Market Report 2026

https://www.thebusinessresearchcompany.com/report/gene-synthesis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the gene expression market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the Gene Expression Market’s size between 2026 and 2030?

The gene expression market has observed substantial growth in recent years. Its size is forecast to expand from $12.67 billion in 2025 to $14.16 billion in 2026, progressing at a compound annual growth rate (CAGR) of 11.7%. The expansion witnessed in previous periods was largely due to increased funding for academic genomics research, a rise in the incidence of chronic and genetic diseases, the initial integration of microarray technologies, the broadening of pharmaceutical R&D pipelines, and the increasing utilization of PCR-based techniques.

The gene expression market is poised for substantial growth in the upcoming years, with projections indicating it will reach $22.22 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 11.9%. This expansion during the forecast period is fueled by advancements in RNA sequencing technologies, a heightened focus on precision medicine, the proliferation of clinical diagnostics applications, the incorporation of AI into gene expression data analysis, and increasing investments within the biotechnology industry. Significant trends anticipated during this period include the wider adoption of single-cell gene expression analysis, enhanced utilization of spatial transcriptomics, a rising demand for high-throughput PCR platforms, the growing integration of multi-omics, and the standardization of gene expression workflows.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9156&type=smp

Which Drivers Are Shaping Strategic Decisions In The Gene Expression Market?

The gene expression market is projected to expand due to an increase in chronic illnesses. These are defined as prolonged medical conditions, generally lasting for at least three months. Gene expression analysis plays a crucial role in chronic disease management by elucidating their underlying molecular processes, identifying potential biological markers, and aiding in the development of targeted treatments. As an illustration, the National Health Service in the UK reported in June 2024 that 3,615,330 people registered with a GP were diagnosed with non-diabetic hyperglycemia, also known as pre-diabetes (a condition characterized by elevated blood sugar levels insufficient for a diabetes diagnosis), in 2023. This figure represents an 18% rise from the 3,065,825 cases recorded in 2022. Consequently, the increasing prevalence of chronic diseases will stimulate the expansion of the gene expression market.

What Segment Categories Are Covered In The Gene Expression Market?

The gene expression market covered in this report is segmented –

1) By Product: Kits And Reagents, DNA Chip Or Microarray, Other Products

2) By Process: Sample Collection, Purification, cDNA Synthesis And Conversion, PCR Analysis, Data Analysis And Interpretation

3) By Technique: RNA Exp, Promoter Analysis, Protein Exp. And Posttranslational Modification Analysis

4) By Application: Drug Discovery And Development, Clinical Diagnostics, Biotechnology And Microbiology, Other Applications

Subsegments:

1) By Kits And Reagents: RNA Isolation Kits, cDNA Synthesis Kits, qPCR Kits, Reverse Transcription Kits, Other Reagents

2) By DNA Chip Or Microarray: Expression Microarrays, Genotyping Microarrays, Comparative Genomic Hybridization Arrays

3) By Other Products: Software For Data Analysis, Lab Instruments, Consumables

Which Trends Are Shaping Activity Within The Gene Expression Market?

Leading companies within the gene expression market are concentrating on developing innovative products, such as gene detection assays, to secure a competitive advantage and boost their revenue. A gene detection assay in gene expression refers to a method for identifying and quantifying genetic molecules, offering insights into the activity and abundance of specific genes. For instance, in January 2023, Bio-Techne Corporation, a US-based biotech company specializing in research instruments, broadened its Advanced Cell Diagnostics (ACD)-branded RNAscope in situ hybridization (ISH) portfolio by launching the RNAscope Plus smRNA-RNA detection assay. This new assay facilitates the simultaneous fluorescent detection of a small regulatory RNA along with three target RNAs or RNA biomarkers in a single tissue section, providing single-cell and subcellular resolution. Designed to support large-scale studies, the assay is compatible with the Leica Bond Rx platform and is offered as a manual assay for ease of use. These therapeutic nucleic acids hold the potential to modulate the expression and functionality of specific target genes, thereby enabling the creation of customized treatments for inherited or acquired diseases that have resisted conventional therapies.

Which Major Industry Participants Are Leading The Gene Expression Market Growth?

Major companies operating in the gene expression market are Thermo Fisher Scientific Inc., Qiagen NV, Illumina Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc., PerkinElmer Inc., GE Healthcare, F Hoffmann-La Roche Ltd, Oxford Gene Technology IP Limited, Promega Corporation, OriGene Technologies Inc., Luminex Corporation, Takara Bio Inc., Danaher Corporation, ELITechGroup, Biocartis Group NV, Integragen SA, Oxford Nanopore Technologies Limited, Phalanx Biotech Group, Roche Holding AG, Sengenics Corporation Pte Ltd., GenXPro GmbH, Twist Bioscience Corporation, Zymo Research Corporation, Abcam plc., Bio-Techne Corporation

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/gene-expression-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Gene Expression Market?

North America was the largest region in the gene expression market in 2025. Asia-Pacific is expected to be the fastest-growing region in the gene expression market in the forecast period. The regions covered in the gene expression market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Gene Expression Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9156&type=smp

Browse Through More Reports Similar to the Global Gene Expression Market 2026, By The Business Research Company

Gene Expression Market Report 2026

https://www.thebusinessresearchcompany.com/report/gene-expression-global-market-report

Protein Expression Market Report 2026

https://www.thebusinessresearchcompany.com/report/protein-expression-global-market-report

Gene Synthesis Market Report 2026

https://www.thebusinessresearchcompany.com/report/gene-synthesis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the gene expression market from 2025–2034 with trusted insights from The Business Research Company

What Is The Present Size Of The Gene Expression Market And What Value Is Projected For 2029?

The gene expression market size has exhibited substantial growth in recent years. It is anticipated to expand from $11.55 billion in 2024 to $12.67 billion in 2025, achieving a compound annual growth rate (CAGR) of 9.7%. This expansion observed during prior periods stemmed from factors such as an increasing emphasis on precision medicine, a surge in cancer research and biomarker discovery, its use in disease diagnosis and prognosis, its integration with systems biology approaches, and the requirements for drug discovery and development.

The gene expression market is projected to experience substantial expansion in the coming years. This market is anticipated to reach “$19.81 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 11.8%. Factors contributing to this growth during the forecast period include the advent of spatial transcriptomics, an increase in epigenomic research, global health crises and readiness for pandemics, a dedicated focus on exploring non-coding RNA, and enhanced application in immunotherapy investigations. Key trends predicted for the forecast period encompass single-cell RNA sequencing, progress in next-generation sequencing, the integration of multi-omics data, breakthroughs in gene editing techniques, the evolution of liquid biopsy, and the application of spatial omics in discovering new drugs.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9156&type=smp

What Factors Are Boosting The Gene Expression Market?

The growing emphasis on precision medicine is anticipated to boost the gene expression market’s expansion moving forward. Precision medicine leverages data regarding a person’s genes or proteins for the diagnosis, prevention, or treatment of illnesses. In precision medicine, gene expression is utilized to detect irregularities in an individual’s normal function and physiological regulation. This is achieved by measuring and comparing genes and transcripts in tissues affected by various medical conditions, thereby facilitating patient-focused treatment. As an illustration, in February 2023, a report from the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, revealed that personalized medicines constituted 35% of new NMEs approved in 2021. Furthermore, with 12 additional approvals in 2022, they have consistently held at least a quarter of new drug approvals over the last eight years, marking a substantial rise from less than 10% a decade prior. Consequently, the heightened emphasis on precision medicine is propelling the gene expression market.

What Are The Core Segmentation Criteria In The Gene Expression Market?

The gene expression market covered in this report is segmented –

1) By Product: Kits And Reagents, DNA Chip Or Microarray, Other Products

2) By Process: Sample Collection, Purification, cDNA Synthesis And Conversion, PCR Analysis, Data Analysis And Interpretation

3) By Technique: RNA Exp, Promoter Analysis, Protein Exp. And Posttranslational Modification Analysis

4) By Application: Drug Discovery And Development, Clinical Diagnostics, Biotechnology And Microbiology, Other Applications

Subsegments:

1) By Kits And Reagents: RNA Isolation Kits, cDNA Synthesis Kits, qPCR Kits, Reverse Transcription Kits, Other Reagents

2) By DNA Chip Or Microarray: Expression Microarrays, Genotyping Microarrays, Comparative Genomic Hybridization Arrays,

3) By Other Products: Software For Data Analysis, Lab Instruments, Consumables

Which Emerging Trends Are Reshaping The Gene Expression Market Landscape?

Technological progress represents a significant trend within the gene expression market. Leading companies in the gene expression market are increasingly focused on RNA gene expression technology. As an illustration, in September 2022, Enzo Biochem, Inc., a US-based biosciences and diagnostics leader, launched AMPIVIEW. This innovative platform is engineered to deliver superior sensitivity for detecting and visualizing biomarkers in cellular and tissue samples. AMPIVIEW is an RNA gene expression platform that employs in-situ hybridization technology to achieve specific and sensitive detection of target genes for HPV and SARS-CoV-2 in tissue or cells, while simultaneously preserving their morphology.

Which Players Are Shaping The Competitive Landscape Of The Gene ExpressionXX Market?

Major companies operating in the gene expression market include Thermo Fisher Scientific Inc., Qiagen NV, Illumina Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc., PerkinElmer Inc., GE Healthcare, F Hoffmann-La Roche Ltd, Oxford Gene Technology IP Limited, Promega Corporation, OriGene Technologies Inc., Luminex Corporation, Takara Bio Inc., Danaher Corporation, ELITechGroup, Biocartis Group NV, Integragen SA, Oxford Nanopore Technologies Limited, Phalanx Biotech Group, Roche Holding AG, Sengenics Corporation Pte Ltd., GenXPro GmbH, Twist Bioscience Corporation, Zymo Research Corporation, Abcam plc., Bio-Techne Corporation

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/gene-expression-global-market-report

What Regional Trends Are Shaping Growth In The Gene Expression Market?

North America was the largest region in the gene expression market in 2024. Asia-Pacific is expected to be the fastest-growing region in the gene expression market in the forecast period. The regions covered in the gene expression market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=9156&type=smp

Browse Through More Reports Similar to the Global Gene Expression Market 2025, By The Business Research Company

Covid 19 Detection Test Kits And Consumables Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/covid-19-detection-test-kits-and-consumables-global-market-report

Covid 19 Rapid Test Kits Market 2025

https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-market

Central Lab Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/central-lab-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the gene expression market from 2025–2034 with trusted insights from The Business Research Company

What Is The Present Size Of The Gene Expression Market And What Value Is Projected For 2029?

The gene expression market size has exhibited substantial growth in recent years. It is anticipated to expand from $11.55 billion in 2024 to $12.67 billion in 2025, achieving a compound annual growth rate (CAGR) of 9.7%. This expansion observed during prior periods stemmed from factors such as an increasing emphasis on precision medicine, a surge in cancer research and biomarker discovery, its use in disease diagnosis and prognosis, its integration with systems biology approaches, and the requirements for drug discovery and development.

The gene expression market is projected to experience substantial expansion in the coming years. This market is anticipated to reach “$19.81 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 11.8%. Factors contributing to this growth during the forecast period include the advent of spatial transcriptomics, an increase in epigenomic research, global health crises and readiness for pandemics, a dedicated focus on exploring non-coding RNA, and enhanced application in immunotherapy investigations. Key trends predicted for the forecast period encompass single-cell RNA sequencing, progress in next-generation sequencing, the integration of multi-omics data, breakthroughs in gene editing techniques, the evolution of liquid biopsy, and the application of spatial omics in discovering new drugs.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9156&type=smp

What Factors Are Boosting The Gene Expression Market?

The growing emphasis on precision medicine is anticipated to boost the gene expression market’s expansion moving forward. Precision medicine leverages data regarding a person’s genes or proteins for the diagnosis, prevention, or treatment of illnesses. In precision medicine, gene expression is utilized to detect irregularities in an individual’s normal function and physiological regulation. This is achieved by measuring and comparing genes and transcripts in tissues affected by various medical conditions, thereby facilitating patient-focused treatment. As an illustration, in February 2023, a report from the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, revealed that personalized medicines constituted 35% of new NMEs approved in 2021. Furthermore, with 12 additional approvals in 2022, they have consistently held at least a quarter of new drug approvals over the last eight years, marking a substantial rise from less than 10% a decade prior. Consequently, the heightened emphasis on precision medicine is propelling the gene expression market.

What Are The Core Segmentation Criteria In The Gene Expression Market?

The gene expression market covered in this report is segmented –

1) By Product: Kits And Reagents, DNA Chip Or Microarray, Other Products

2) By Process: Sample Collection, Purification, cDNA Synthesis And Conversion, PCR Analysis, Data Analysis And Interpretation

3) By Technique: RNA Exp, Promoter Analysis, Protein Exp. And Posttranslational Modification Analysis

4) By Application: Drug Discovery And Development, Clinical Diagnostics, Biotechnology And Microbiology, Other Applications

Subsegments:

1) By Kits And Reagents: RNA Isolation Kits, cDNA Synthesis Kits, qPCR Kits, Reverse Transcription Kits, Other Reagents

2) By DNA Chip Or Microarray: Expression Microarrays, Genotyping Microarrays, Comparative Genomic Hybridization Arrays,

3) By Other Products: Software For Data Analysis, Lab Instruments, Consumables

Which Emerging Trends Are Reshaping The Gene Expression Market Landscape?

Technological progress represents a significant trend within the gene expression market. Leading companies in the gene expression market are increasingly focused on RNA gene expression technology. As an illustration, in September 2022, Enzo Biochem, Inc., a US-based biosciences and diagnostics leader, launched AMPIVIEW. This innovative platform is engineered to deliver superior sensitivity for detecting and visualizing biomarkers in cellular and tissue samples. AMPIVIEW is an RNA gene expression platform that employs in-situ hybridization technology to achieve specific and sensitive detection of target genes for HPV and SARS-CoV-2 in tissue or cells, while simultaneously preserving their morphology.

Which Players Are Shaping The Competitive Landscape Of The Gene ExpressionXX Market?

Major companies operating in the gene expression market include Thermo Fisher Scientific Inc., Qiagen NV, Illumina Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc., PerkinElmer Inc., GE Healthcare, F Hoffmann-La Roche Ltd, Oxford Gene Technology IP Limited, Promega Corporation, OriGene Technologies Inc., Luminex Corporation, Takara Bio Inc., Danaher Corporation, ELITechGroup, Biocartis Group NV, Integragen SA, Oxford Nanopore Technologies Limited, Phalanx Biotech Group, Roche Holding AG, Sengenics Corporation Pte Ltd., GenXPro GmbH, Twist Bioscience Corporation, Zymo Research Corporation, Abcam plc., Bio-Techne Corporation

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/gene-expression-global-market-report

What Regional Trends Are Shaping Growth In The Gene Expression Market?

North America was the largest region in the gene expression market in 2024. Asia-Pacific is expected to be the fastest-growing region in the gene expression market in the forecast period. The regions covered in the gene expression market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=9156&type=smp

Browse Through More Reports Similar to the Global Gene Expression Market 2025, By The Business Research Company

Covid 19 Detection Test Kits And Consumables Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/covid-19-detection-test-kits-and-consumables-global-market-report

Covid 19 Rapid Test Kits Market 2025

https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-market

Central Lab Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/central-lab-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Gene Expression Market By 2029?

The gene expression market has demonstrated significant growth in recent years. This market is projected to expand from $11.55 billion in 2024 to $12.67 billion in 2025, at a compound annual growth rate (CAGR) of 9.7%. The historical expansion of this market can be attributed to several factors, including an increased focus on precision medicine, the rise of cancer research and biomarker discovery, its application in disease diagnosis and prognosis, its integration with systems biology approaches, and the needs for drug discovery and development.

The gene expression market is set for substantial expansion in the coming years. It is forecast to achieve a valuation of $19.81 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 11.8%. This expansion throughout the forecast period is fueled by the emergence of spatial transcriptomics, a rise in epigenomic studies, global health events and pandemic preparedness efforts, a focus on exploring non-coding RNA, and increased application in immunotherapy research. Prominent trends anticipated in the forecast period include single-cell RNA sequencing, advancements in next-generation sequencing, the integration of multi-omics data, progress in gene editing technologies, the development of liquid biopsy, and the utilization of spatial omics in drug discovery.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9156&type=smp

Which Drivers Are Impacting The Gene Expression Market?

The anticipated expansion of the gene expression market is set to be fueled by a greater emphasis on precision medicine in the coming period. This approach utilizes data concerning an individual’s genetic makeup or proteins for the purposes of diagnosing, preventing, or managing illnesses. Within precision medicine, gene expression is employed to pinpoint deviations from typical function and physiological control in an individual. This is achieved through the measurement and comparison of genes and transcripts found in tissues experiencing various medical conditions, thereby facilitating treatment tailored to the patient. As an illustration, a February 2023 report from the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, indicated that personalized medicines constituted 35% of novel NME approvals in 2021. Furthermore, with 12 new approvals in 2022, these medicines have consistently represented at least a quarter of all new drug approvals over the preceding eight years, marking a substantial rise from less than 10% a decade prior. Consequently, the heightened attention on precision medicine is serving as a catalyst for the gene expression market.

How Is The Gene Expression Market Segmented?

The gene expression market covered in this report is segmented –

1) By Product: Kits And Reagents, DNA Chip Or Microarray, Other Products

2) By Process: Sample Collection, Purification, cDNA Synthesis And Conversion, PCR Analysis, Data Analysis And Interpretation

3) By Technique: RNA Exp, Promoter Analysis, Protein Exp. And Posttranslational Modification Analysis

4) By Application: Drug Discovery And Development, Clinical Diagnostics, Biotechnology And Microbiology, Other Applications

Subsegments:

1) By Kits And Reagents: RNA Isolation Kits, cDNA Synthesis Kits, qPCR Kits, Reverse Transcription Kits, Other Reagents

2) By DNA Chip Or Microarray: Expression Microarrays, Genotyping Microarrays, Comparative Genomic Hybridization Arrays,

3) By Other Products: Software For Data Analysis, Lab Instruments, Consumables

Which Market Trends Are Creating New Opportunities In The Gene Expression Industry?

Technological progress represents a significant trend within the gene expression market. Leading companies engaged in the gene expression market are increasingly adopting RNA gene expression technology. As an example, in September 2022, Enzo Biochem, Inc., a prominent US-based biosciences and diagnostics firm, introduced AMPIVIEW, a novel platform engineered to offer enhanced sensitivity for identifying and visualizing biomarkers in cellular and tissue samples. AMPIVIEW functions as an RNA gene expression platform, employing in-situ hybridization technology for the identification of HPV and SARS-CoV-2 through the precise and sensitive detection of target genes within tissue or cells, all while maintaining their morphology.

Which Major Industry Participants Are Leading The Gene Expression Market Growth?

Major companies operating in the gene expression market include Thermo Fisher Scientific Inc., Qiagen NV, Illumina Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc., PerkinElmer Inc., GE Healthcare, F Hoffmann-La Roche Ltd, Oxford Gene Technology IP Limited, Promega Corporation, OriGene Technologies Inc., Luminex Corporation, Takara Bio Inc., Danaher Corporation, ELITechGroup, Biocartis Group NV, Integragen SA, Oxford Nanopore Technologies Limited, Phalanx Biotech Group, Roche Holding AG, Sengenics Corporation Pte Ltd., GenXPro GmbH, Twist Bioscience Corporation, Zymo Research Corporation, Abcam plc., Bio-Techne Corporation

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/gene-expression-global-market-report

How Is Gene Expression Market Demand Varying Across Different Regions?

North America was the largest region in the gene expression market in 2024. Asia-Pacific is expected to be the fastest-growing region in the gene expression market in the forecast period. The regions covered in the gene expression market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Gene Expression Market Report:

https://www.thebusinessresearchcompany.com/customise?id=9156&type=smp

Browse Through More Reports Similar to the Global Gene Expression Market 2025, By The Business Research Company

Covid 19 Detection Test Kits And Consumables Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/covid-19-detection-test-kits-and-consumables-global-market-report

Covid 19 Rapid Test Kits Market 2025

https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-market

Central Lab Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/central-lab-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What CAGR And Valuation Are Anticipated For The Gene Expression Market?

In recent years, the gene expression market size has seen a robust growth. It is projected to increase from $11.55 billion in 2024 to $12.67 billion in 2025, with a compound annual growth rate (CAGR) of 9.7%. This growth during the historical period can be credited to factors such as greater emphasis on precision medicine, a surge in cancer research and biomarker discovery, its use in disease diagnosis and prognosis, incorporation with systems biology approaches, and requirements of drug discovery and development.

The market size for gene expression is predicted to experience significant expansion in the coming years. It’s projected to reach a market cap of $19.81 billion by 2029, growing at a compound annual growth rate (CAGR) of 11.8%. The expected growth during the forecast period can be attributed to various factors such as the emergence of spatial transcriptomics, an increase in epigenomic research, global health incidents and planning for pandemics, emphasis on the exploration of non-coding RNA, and increased usage in immunotherapy research. Some of the major projected trends for this period encompass single-cell RNA sequencing, advancements in next-gen sequencing, the integration of multi-omics data, progress in gene editing technologies, development of liquid biopsy, and the use of spatial omics in drug discovery.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9156&type=smp

Which Demand Drivers Are Strengthening The Gene Expression Market?

The growth of the gene expression market is expected to be fueled by the intensified focus on precision medicine. Precision medicine uses the understanding of a person’s genomic information or proteins to diagnose, prevent and formulate the appropriate treatment of a disease. The technology of gene expression plays a critical role in precision medicine, as it helps in identifying abnormalities and monitors normal function and physiologic regulation in an individual. It accomplishes this by measuring and comparing genes and transcripts in various tissues under different medical conditions. This method guides more patient-focused treatment protocols. For example, a report from the Personalized Medicine Coalition, a non-profit organization based in the US, in February 2023, stated that personalized medicines accounted for 35% of the newly approved NMEs in 2021. Plus, with 12 additional approvals in 2022, these medications have sustained a steady share of at least 25% of new drug approvals over the last eight years. This shows a considerable increase from less than 10% just ten years ago. Hence, this growing emphasis on precision medicine is significantly affecting the progression of the gene expression market.

What Are The Primary Segmentation Parameters In The Gene Expression Market?

The gene expression market covered in this report is segmented –

1) By Product: Kits And Reagents, DNA Chip Or Microarray, Other Products

2) By Process: Sample Collection, Purification, cDNA Synthesis And Conversion, PCR Analysis, Data Analysis And Interpretation

3) By Technique: RNA Exp, Promoter Analysis, Protein Exp. And Posttranslational Modification Analysis

4) By Application: Drug Discovery And Development, Clinical Diagnostics, Biotechnology And Microbiology, Other Applications

Subsegments:

1) By Kits And Reagents: RNA Isolation Kits, cDNA Synthesis Kits, qPCR Kits, Reverse Transcription Kits, Other Reagents

2) By DNA Chip Or Microarray: Expression Microarrays, Genotyping Microarrays, Comparative Genomic Hybridization Arrays,

3) By Other Products: Software For Data Analysis, Lab Instruments, Consumables

Which Emerging Trends Are Reshaping The Gene Expression Market Landscape?

A primary trend in the gene expression market is the progression in technology. Leading companies in the sector are increasingly adopting the RNA gene expression technology. To illustrate, Enzo Biochem, Inc., a biosciences and diagnostics giant hailing from the U.S., introduced AMPIVIEW in September 2022. This new platform is innovatively devised for enhanced sensitivity in detecting and visualizing biomarkers in cellular and tissue samples. AMPIVIEW uses in-situ hybridization technology for the identification of HPV and SARS-CoV-2, and offers a precise and sensitive discovery method for target genes in tissues or cells, while keeping the morphology preserved.

Which Players Are Shaping The Competitive Landscape Of The Gene Expression Market?

Major companies operating in the gene expression market include Thermo Fisher Scientific Inc., Qiagen NV, Illumina Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc., PerkinElmer Inc., GE Healthcare, F Hoffmann-La Roche Ltd, Oxford Gene Technology IP Limited, Promega Corporation, OriGene Technologies Inc., Luminex Corporation, Takara Bio Inc., Danaher Corporation, ELITechGroup, Biocartis Group NV, Integragen SA, Oxford Nanopore Technologies Limited, Phalanx Biotech Group, Roche Holding AG, Sengenics Corporation Pte Ltd., GenXPro GmbH, Twist Bioscience Corporation, Zymo Research Corporation, Abcam plc., Bio-Techne Corporation

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/gene-expression-global-market-report

What Are The Emerging Regional Trends Driving The Gene Expression Market?

North America was the largest region in the gene expression market in 2024. Asia-Pacific is expected to be the fastest-growing region in the gene expression market in the forecast period. The regions covered in the gene expression market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=9156&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model